Cancers | Free Full-Text | Correlation between BAP1 Localization, Driver Mutations, and Patient Survival in Uveal Melanoma
Frontiers | Role of BRCA Mutations in the Modulation of Response to Platinum Therapy
IJMS | Free Full-Text | Endocrine Disruptors and Endometrial Cancer: Molecular Mechanisms of Action and Clinical Implications, a Systematic Review
Calcium homeostasis and cancer: insights from endoplasmic reticulum-centered organelle communications: Trends in Cell Biology
Large‐scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma - De Rienzo - 2021 - The Journal of Pathology - Wiley Online Library
Intrinsic apoptosis shapes the tumor spectrum linked to inactivation of the deubiquitinase BAP1 | Science
BAP1 and cancer | Nature Reviews Cancer
Schematic block diagram representing the operations performed by the... | Download Scientific Diagram
UMs with focal perinuclear cBAP1 tend to harbour loss-of-function BAP1... | Download Scientific Diagram
The convergence of tumor suppressors on the type I interferon pathway in clear cell renal cell carcinoma and its therapeutic implications | American Journal of Physiology-Cell Physiology
Tumor suppressor BAP1 nuclear import is governed by transportin-1 | Journal of Cell Biology | Rockefeller University Press
Broadcast Audio Processor - Ross Video
Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression | Nature Communications
Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. | Semantic Scholar
BAP1 activity regulates PcG occupancy and global chromatin condensation counteracting diffuse PCGF3/5-dependent H2AK119ub1 deposition | bioRxiv
The BAP1 deubiquitinase complex is a general transcriptional co-activator | bioRxiv
Cancers | Free Full-Text | Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma
Frontiers | BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors